Mitochondrial Genome Deletion for Detection of Prostate Cancer
- Aliases
-
- Mitochondrial Genome Deletion for Detection of Prostate Cancer
- Mitochondrial deletion for detection of prostate cancer
- Prostate Core Mitomic Test
- Prostate Core Mitomic Test™
- Description
- The Prostate Core Mitomic Test is based upon a 3.4 kb mitochondrial genome deletion (3.4 mtdelta) that was identified through PCR analysis of frozen prostate cancer samples. In cancer research it has been found that deletions in mitochondrial DNA can correlate with cellular changes that indicate development of cancer. This deletion includes the terminal 22 bases of MT-ND4L, all of MT-ND4, 3 tRNAs (histidine, serine 2, and leucine 2), and all except the terminal 24 bases of MT-ND5.
Attributes
- QA State
- Curated
- Type
- Genomic
- HGNC Name
- Certifications
- QA State for Prostate
- Curated
Non-Public Biomarker
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access.
Non-Public Biomarker
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access.
Non-Public Biomarker
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access.